SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Anticancer Drugs Might be of Benefit to Sickle-Cell Patients
December 7, 2007
 · 
1 min read
Drug Development
A New Approach to Study Flu Drug Resistance
December 7, 2007
 · 
1 min read
Drug Development
UT Southwestern Medical Center Urologist Uses Botox to Treat Debilitating Condition
December 5, 2007
 · 
1 min read
Drug Development
Study Questions Drug Treatments for Sinus Ills
December 5, 2007
 · 
1 min read
Drug Development
FDA: Studies Behind Cold Meds Are Weak
December 4, 2007
 · 
1 min read
Drug Development
Modifying an Anti-Cancer Drug Makes it More Specific
December 4, 2007
 · 
1 min read
Drug Development
Study Explains GlaxoSmithKline’s Diabetes Drug Bone Fracture Risk
December 3, 2007
 · 
1 min read
Drug Development
Ibuprofen Associated with Slower Lung Function Decline in Children with Cystic Fibrosis
November 30, 2007
 · 
1 min read
Drug Development
Drug Monitoring Reduces Seizures in Pregnant Women with Epilepsy
November 29, 2007
 · 
1 min read
Drug Development
New Computational Technique Predicts Side-effects Of Major Cancer Drug
November 28, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Spectrum Pharmaceuticals, Inc. Anemia Drug Works as Well as Approved Drugs, FDA Says
December 5, 2011
 · 
1 min read
Drug Development
Regeneron Pharmaceuticals, Inc.-Bayer HealthCare Drug Matches Lucentis at 2 Years in Fewer Doses
December 5, 2011
 · 
12 min read
Business
FDA, Shire Reach Deal on ProAmatine Trials
December 5, 2011
 · 
5 min read
Drug Development
FDA Rejects Genentech’s Avastin for Breast Cancer
November 18, 2011
 · 
9 min read
Drug Development
Eli Lilly and Company Release: New Analysis of Data Presented at AHA Regarding Effect of Effient(R) (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
November 17, 2011
 · 
11 min read
Drug Development
Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax Regimen for Post-Exposure Prophylaxis
November 17, 2011
 · 
1 min read
Drug Development
FDAAdvisoryCommittee.com : Salix Pharmaceuticals, Ltd. Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN® for Irritable Bowel Syndrome with Diarrhea
November 17, 2011
 · 
1 min read
Drug Development
American Heart Association Release: Triple-Dose Clopidogrel Can Work in People With Genetic Resistance
November 16, 2011
 · 
1 min read
Drug Development
American Heart Association Release: Gout Drug Reduces Incidence of Irregular Heartbeat After Surgery
November 16, 2011
 · 
1 min read
Drug Development
Fitch: New Use of Johnson & Johnson’s JNJ Blood Thinner Could Thicken Cash
November 16, 2011
 · 
1 min read
Drug Development
BioSante Pharmaceuticals, Inc. Announces Positive LibiGel® Pharmacokinetic Study Results
November 16, 2011
 · 
6 min read
Drug Development
Abbott Laboratories Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
November 15, 2011
 · 
6 min read
Drug Development
PhaseBio Pharmaceuticals, Inc. Announces Positive Clinical Results with its Once Weekly GLP-1 analogue, Glymera™ for the Treatment of Hyperglycemia in Patients with Type 2 Diabetes
November 15, 2011
 · 
1 min read
Drug Development
American Heart Association Release: If Bad Cholesterol is Controlled, Adding Niacin Won’t Lower Heart Attack, Stroke Risk
November 15, 2011
 · 
1 min read
Drug Development
Phase Bioscience, Inc. Announces Positive Clinical Results with its Once Weekly GLP-1 Analogue, Glymera™ for the Treatment of Hyperglycemia in Patients with Type 2 Diabetes
November 15, 2011
 · 
1 min read
Drug Development
Sanofi (France)'s Multaq Doubled Deaths from Heart Disease in Study
November 15, 2011
 · 
1 min read
Drug Development
AstraZeneca Pharmaceuticals LP Release: Saturn Demonstrated Effect of Intensive Statin Treatment on Reducing Atherosclerosis
November 15, 2011
 · 
1 min read
Drug Development
Synta Pharmaceuticals Presents Results on Ganetespib and Hsp90 Inhibitor Class at the American Association for Cancer Research-European Organization for Research and Treatment of Cancer-National Cancer Institute Molecular Targets and Cancer Therapeutics C
November 15, 2011
 · 
1 min read
Drug Development
Midatech Group Receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles
November 15, 2011
 · 
1 min read
Drug Development
Pfizer Inc. Release: New Data Presented On Phase 3 Trial of ELIQUIS® (apixaban) In the Prevention Of Venous Thromboembolism in Patients With Acute Medical Illness
November 14, 2011
 · 
8 min read
Load More